Shrish Enterprises Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 9.00 M
as on 17-07-2024
- Company Age 24 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.00 Cr
as on 17-07-2024
- Satisfied Charges ₹ 20.35 Cr
as on 17-07-2024
- Revenue 8.79%
(FY 2023)
- Profit 13.05%
(FY 2023)
- Ebitda 29.17%
(FY 2023)
- Net Worth 12.22%
(FY 2023)
- Total Assets 3.36%
(FY 2023)
About Shrish Enterprises
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.00 M.
The company currently has active open charges totaling ₹9.00 Cr. The company has closed loans amounting to ₹20.35 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ramesh Goel and Naresh Goel serve as directors at the Company.
- CIN/LLPIN
U24239DL2000PTC104638
- Company No.
104638
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Mar 2000
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shrish Enterprises?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Goel  | Director | 23-Mar-2000 | Current |
| Naresh Goel | Director | 23-Mar-2000 | Current |
Financial Performance and Corporate Structure Insights of Shrish Enterprises.
Shrish Enterprises Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.79% increase. The company also saw a substantial improvement in profitability, with a 13.05% increase in profit. The company's net worth Soared by an impressive increase of 12.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shrish Enterprises?
In 2023, Shrish Enterprises had a promoter holding of 85.98% and a public holding of 14.02%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Recova Pharma Expo Private LimitedActive 18 years 9 monthsRamesh Goel and Naresh Goel are mutual person
- Sentosa Geigy (India) Labs LimitedActive 14 years 10 months
Ramesh Goel and Naresh Goel are mutual person
- Gangesh Pharma Private LimitedActive 25 years 9 months
Ramesh Goel and Naresh Goel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 15 Mar 2021 | ₹9.00 Cr | Open |
Others Creation Date: 15 Nov 2016 | ₹8.00 Cr | Satisfied |
Axis Bank Limited Creation Date: 28 Jul 2009 | ₹9.75 Cr | Satisfied |
How Many Employees Work at Shrish Enterprises?
Unlock and access historical data on people associated with Shrish Enterprises, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shrish Enterprises, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shrish Enterprises's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
